McKinley Capital Management’s West Pharmaceutical WST Stock Holding History

McKinley Capital Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-12,160	Closed	-$4.81M	–	161
2024 Q1	$4.81M	Sell	12,160 -5,490	-31%	-$2.03M	0.58%	63
2023 Q4	$6.21M	Hold	17,650	–	–	0.8%	41
2023 Q3	$6.62M	Hold	17,650	–	–	0.93%	27
2023 Q2	$6.75M	Sell	17,650 -2,300	-12%	-$822K	0.9%	29
2023 Q1	$6.91M	Hold	19,950	–	–	0.92%	30
2022 Q4	$4.7M	Hold	19,950	–	–	0.63%	60
2022 Q3	$4.91M	Hold	19,950	–	–	0.67%	49
2022 Q2	$6.03M	Hold	19,950	–	–	0.79%	36
2022 Q1	$8.19M	Hold	19,950	–	–	0.82%	34
2021 Q4	$9.36M	Hold	19,950	–	–	0.84%	30
2021 Q3	$8.47M	Hold	19,950	–	–	0.8%	29
2021 Q2	$7.16M	Buy	19,950 +4,150	+26%	+$1.37M	0.5%	61
2021 Q1	$4.45M	Hold	15,800	–	–	0.34%	83
2020 Q4	$4.48M	Hold	15,800	–	–	0.32%	87
2020 Q3	$4.34M	Hold	15,800	–	–	0.34%	84
2020 Q2	$3.59M	Hold	15,800	–	–	0.24%	92
2020 Q1	$2.41M	Hold	15,800	–	–	0.19%	99
2019 Q4	$2.38M	Buy	+15,800	New	+$2.3M	0.15%	112
2019 Q3	–	Sell	-15,800	Closed	-$1.98M	–	213
2019 Q2	$1.98M	Buy	+15,800	New	+$1.86M	0.13%	112

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

McKinley Capital Management's WST Position: Q2 2024 in Review

McKinley Capital Management sold out of West Pharmaceutical (WST) in Q2 2024, closing a stake of 12,160 shares — an estimated $4.81M sold.

McKinley Capital Management first reported a position in WST in Q2 2019 and held it in 19 quarters. The position peaked at $9.36M in Q4 2021. 777 funds tracked by Wall St. Rank hold WST as of Q2 2024.

McKinley Capital Management reported no remaining West Pharmaceutical position as of Q2 2024 after selling out during the quarter.
McKinley Capital Management sold 12,160 West Pharmaceutical shares in Q2 2024, an estimated $4.81M.
McKinley Capital Management first reported a position in West Pharmaceutical in Q2 2019 and held it in 19 quarters.
McKinley Capital Management's West Pharmaceutical position peaked at $9.36M in Q4 2021.
777 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2024.

Based on McKinley Capital Management's 13F filing for Q2 2024, filed 12 Aug 2024.